These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 2382101)

  • 1. Evaluation of an arsenical compound (RM 110, mel Cy, Cymelarsan) against susceptible and drug-resistant Trypanosoma brucei brucei and T.b. evansi.
    Zweygarth E; Kaminsky R
    Trop Med Parasitol; 1990 Jun; 41(2):208-12. PubMed ID: 2382101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary observations on the efficacy of mel Cy (Cymelarsan) in domestic animals infected with stocks of Trypanosoma brucei brucei and T.b. evansi.
    Zweygarth E; Ngeranwa J; Kaminsky R
    Trop Med Parasitol; 1992 Dec; 43(4):226-8. PubMed ID: 1293725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
    Zweygarth E; Kaminsky R
    Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanocidal activity of a 5-substituted 2-nitroimidazole compound (Ro 15-0216) in mice.
    Zweygarth E; Röttcher D
    Trop Med Parasitol; 1987 Sep; 38(3):171-4. PubMed ID: 3432951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in properties of adenosine transporters in Trypanosoma evansi and modes of selection of resistance to the melaminophenyl arsenical drug, Mel Cy.
    Suswam EA; Taylor DW; Ross CA; Martin RJ
    Vet Parasitol; 2001 Dec; 102(3):193-208. PubMed ID: 11777599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of resistance to melarsenoxide cysteamine (Mel Cy) in Trypanosoma brucei brucei.
    Pospichal H; Brun R; Kaminsky R; Jenni L
    Acta Trop; 1994 Dec; 58(3-4):187-97. PubMed ID: 7709858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of experimental trypanocidal compounds against a multiple drug-resistant Trypanosoma brucei brucei stock in mice.
    Zweygarth E; Röttcher D
    Parasitol Res; 1989; 75(3):178-82. PubMed ID: 2710771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of a T. b. rhodesiense stock with reduced drug susceptibility in vitro to treatment in mice and cattle.
    Enyaru JC; Matovu E; Lubega GW; Kaminsky R
    Acta Trop; 1998 Jun; 69(3):261-9. PubMed ID: 9638278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacy of melarsen oxide compared with mel Cy (Cymelarsan) when used in combination with difluoromethylornithine in the treatment of trypanosomiasis of the central nervous system.
    Jennings FW
    Trans R Soc Trop Med Hyg; 1992; 86(3):257-8. PubMed ID: 1412647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spiroarsoranes of second generation: evaluation of trypanocidal properties against Trypanosoma brucei brucei.
    Loiseau PM; Wolf JG; Gayral P
    Trop Med Parasitol; 1993 Mar; 44(1):32-6. PubMed ID: 8516630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of in vitro cultivation on the stability of resistance of Trypanosoma brucei brucei to diminazene, isometamidium, quinapyramine, and Mel B.
    Kaminsky R; Zweygarth E
    J Parasitol; 1989 Feb; 75(1):42-5. PubMed ID: 2918443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.
    Yarlett N; Goldberg B; Nathan HC; Garofalo J; Bacchi CJ
    Exp Parasitol; 1991 Feb; 72(2):205-15. PubMed ID: 1849084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital lesions in male red fronted gazelles (Gazella rufifrons) experimentally infected with Trypanosoma brucei and the effect of melarsamine hydrochloride (Cymelarsan®) and diminazene aceturate (Berenil®) in its treatment.
    Mbaya AW; Nwosu CO; Kumshe HA
    Theriogenology; 2011 Sep; 76(4):721-8. PubMed ID: 21601916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
    Scott AG; Tait A; Turner CM
    Exp Parasitol; 1997 Jul; 86(3):181-90. PubMed ID: 9225768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cymelarsan in the treatment of buffaloes naturally infected with Trypanosoma evansi in south China.
    Lun ZR; Min ZP; Huang D; Liang JX; Yang XF; Huang YT
    Acta Trop; 1991 Aug; 49(3):233-6. PubMed ID: 1685304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic and old taxa: subspeciation and drug sensitivity in Trypanosoma brucei.
    Dukes P
    Trans R Soc Trop Med Hyg; 1984; 78(6):711-25. PubMed ID: 6241967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diminazene-resistant strain of Trypanosoma brucei brucei isolated from a dog is cross-resistant to pentamidine in experimentally infected albino rats.
    Anene BM; Ezeokonkwo RC; Mmesirionye TI; Tettey JN; Brock JM; Barrett MP; De Koning HP
    Parasitology; 2006 Jan; 132(Pt 1):127-33. PubMed ID: 16393361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma brucei brucei: expression of drug resistance in vitro.
    Kaminsky R; Chuma F; Zweygarth E
    Exp Parasitol; 1989 Oct; 69(3):281-9. PubMed ID: 2792303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of combination of DFMO and diminazene aceturate in the treatment of late stage Trypanosoma brucei brucei infection in rats.
    Onyeyili PA; Onwualu JE
    Trop Med Parasitol; 1991 Jun; 42(2):143-5. PubMed ID: 1896772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary efficacy trial of Cymelarsan in mice artificially infected with Trypanosoma brucei brucei isolated from a dog in Zambia.
    Syakalima M; Yasuda J; Hashimoto A
    Jpn J Vet Res; 1995 Sep; 43(2):93-7. PubMed ID: 7474644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.